Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Pancreatic Cyst 1Neoplasms 1Esophageal Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Defecation × 1 year × Clear all
NCT03855800 2026-06-02

Molecular Detection of Advanced Neoplasia in Pancreatic Cysts

Mayo Clinic

Phase NA Recruiting
800 enrolled
Gastrointestinal

Pancreatic Cyst

NCT06123338 2026-05-28

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
49 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04970472 2026-03-19

MicroBlad

University Hospital, Toulouse

Recruiting
1,000 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡